ARROWSTREET CAPITAL, LIMITED PARTNERSHIP - QIAGEN NV ownership

QIAGEN NV's ticker is QGEN and the CUSIP is N72482123. A total of 278 filers reported holding QIAGEN NV in Q3 2023. The put-call ratio across all filers is 0.42 and the average weighting 0.2%.

Quarter-by-quarter ownership
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP ownership history of QIAGEN NV
ValueSharesWeighting
Q3 2023$25,353
-58.1%
626,379
-53.5%
0.03%
-58.1%
Q2 2023$60,485
-52.3%
1,346,272
-51.5%
0.07%
-54.9%
Q1 2023$126,690
-31.7%
2,773,053
-25.1%
0.16%
-36.7%
Q4 2022$185,374
-99.9%
3,700,311
+6.2%
0.26%
+21.0%
Q3 2022$145,436,000
-8.6%
3,484,836
+3.0%
0.21%
-4.9%
Q2 2022$159,076,000
-7.5%
3,383,973
-3.3%
0.22%
+4.7%
Q1 2022$171,979,000
+0.8%
3,498,030
+14.2%
0.22%
+2.9%
Q4 2021$170,550,000
+100.0%
3,063,558
+85.9%
0.21%
+95.3%
Q3 2021$85,290,000
+1615.1%
1,648,011
+1502.4%
0.11%
+1683.3%
Q2 2021$4,973,000
-85.1%
102,848
-83.8%
0.01%
-87.2%
Q4 2020$33,316,000
+56.1%
636,678
+55.3%
0.05%
+38.2%
Q3 2020$21,338,000
-22.0%
410,075
-35.6%
0.03%
-32.0%
Q2 2020$27,359,000
+379.4%
637,111
+278.7%
0.05%
+284.6%
Q4 2019$5,707,000
-16.4%
168,225
-18.8%
0.01%
-18.8%
Q3 2019$6,826,000
+38.0%
207,284
+70.0%
0.02%
+45.5%
Q2 2019$4,947,000
-61.0%
121,945
-60.9%
0.01%
-63.3%
Q1 2019$12,690,000
-57.9%
312,006
-60.8%
0.03%
-55.9%
Q3 2018$30,121,000
+7.0%
795,571
+2.6%
0.07%
-1.4%
Q2 2018$28,141,000
+320.7%
775,384
+260.5%
0.07%
+331.2%
Q4 2017$6,689,000
-69.2%
215,058
-68.8%
0.02%
-72.4%
Q3 2017$21,731,000
-17.7%
690,161
-12.4%
0.06%
-27.5%
Q2 2017$26,408,000787,6000.08%
Other shareholders
QIAGEN NV shareholders Q3 2023
NameSharesValueWeighting ↓
Nekton Capital Ltd. 1,733,397$78,054,86712.79%
Varenne Capital Partners 607,000$27,248,17612.70%
SYCOMORE ASSET MANAGEMENT 427,987$18,9124.42%
Grandeur Peak Global Advisors, LLC 910,418$40,996,1232.80%
Endurant Capital Management LP 62,708$2,823,7412.46%
Susquehanna International Securities, Ltd. 42,661$1,921,0251.79%
Susquehanna International Group Ltd. 41,707$1,878,0661.51%
SECTOR GAMMA AS 127,526$5,742,4961.28%
Perpetual Ltd 2,654,773$119,544,4281.02%
Southpoint Capital Advisors LP 1,000,000$45,030,0000.98%
View complete list of QIAGEN NV shareholders